NASDAQ: HUGE - FSD Pharma Inc.

Yield per half year: 0%
Dividend yield: 0.00%
Sector: Healthcare

Share chart FSD Pharma Inc.

Extended chart Simple chart
Financial Markets by TradingView

About FSD Pharma Inc.

FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD-201, an ultra-micronized palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. was incorporated in 1998 and is headquartered in Toronto, Canada.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2018-06-08
ISIN CA35954B2066
Industry IT Services
Sector Information Technology
Валюта usd
Валюта отчета usd
Сайт https://www.fsdpharma.com
Цена ао 5.39
Change price per day: 0% (5.39)
Change price per week: 0% (5.39)
Change price per month: 0% (5.39)
Change price per 3 month: 0% (5.39)
Change price per half year: 0% (5.39)
Change price per year: +930.79% (0.5229)
Change price per 3 year: +473.4% (0.94)
Change price per 5 year: +102.63% (2.66)
Change price per year to date: 0% (5.39)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 189.74 1
P/E 0 0
EV/EBITDA -140.1 0
Total: 0.375

Efficiency

Title Value Grade
ROA, % -106.78 0
ROE, % -140.97 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0194 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % -98.84 0
Yield Ebitda, % -31.32 0
Yield EPS, % -91.74 0
Total: 0
More

Institutions Volume Share, %
AdvisorShares Investments, LLC 270316 0.67
Renaissance Technologies, LLC 69200 0.17
Scotia Capital Inc. 61273 0.15
UBS Group AG 26362 0.07
Group One Trading, L.P. 17653 0.04
TWO SIGMA SECURITIES, LLC 13584 0.03
Susquehanna International Group, LLP 11791 0.03
Td Waterhouse Canada Inc. 10373 0.03
Citadel Advisors Llc 2483 0.01
Royal Bank of Canada 2450 0.01



Head Job title Payment Year of birth
Mr. Zeeshan Saeed Founder, CEO, President & Executive Co-Chairman 222.62k 1970 (55 years)
Mr. Anthony John Durkacz Founder & Executive Co-Chairman 222.62k 1976 (49 years)
Mr. Nathan Coyle CPA Chief Financial Officer 178.21k 1981 (44 years)
Mr. Donal Carroll CPA Chief Operating Officer 225.62k 1977 (48 years)
Dr. Lakshmi P. Kotra BPHARM, Ph.D. CEO of Lucid & Director 144.72k 1971 (54 years)
Dr. Andrzej Chruscinski M.D., Ph.D. Vice President of Clinical & Scientific Affairs of Lucid 110.3k
Mr. Kevin Cassidy Vice President of Quality-Lucid 144.82k
Ms. Maryann Adesso Corporate Secretary N/A
Randell Mack President of FSD BioSciences N/A

Address: Canada, Toronto. ON ML A, 199 Bay Street - open in Google maps, open in Yandex maps
Website: https://www.fsdpharma.com